RE: New CEO10 Sep 2024 13:20
PMJH - I agree. However as Karley suggests, maybe the new entity of TFG as opposed to Polygon came with a speedier team at the helm (as I understand it, Polygon was created as a hedge within TFG with Griffiths involved in both). Perhaps rather than a 20 year timeline with this company, they've now been forced to work on that 5 year timeline.
Trials aside, TFG are surely aware of the going-concern/audit problem and the consequences of keeping the company on a right track (if not 'the' right track) in order to keep the company afloat, get a good trial going with a good probability of success, and therefore get this going-concern situation controlled. By doing all of this, the company remains afloat, they turn the tide in a matter of months, and they begin moving the valuation of this company in a positive direction.
They said it themselves - "sometimes we're involved in a business that's never gonna be bigger than 300-400 million". That was his worst-case scenario in that interview. What's Synairgen worth right now, 8 million? Is this not a reason they may have stepped in before that five year window actually ends, as the company seemed to be going backwards toward the end of their five year window rather than forwards? This is what I'm choosing to believe and I choose to believe it bodes well for us.